121 related articles for article (PubMed ID: 20328092)
1. Mass Screening.
Can Med Assoc J; 1965 Jan; 92(4):193-4. PubMed ID: 20328092
[No Abstract] [Full Text] [Related]
2. Value of mass screening for thyroid cancer.
Miki H; Inoue H; Komaki K; Uyama T; Morimoto T; Monden Y
World J Surg; 1998 Jan; 22(1):99-102. PubMed ID: 9465769
[TBL] [Abstract][Full Text] [Related]
3. [A case-control study on the efficacy and the optimum interval of mass screening for prostatic cancer].
Nakagawa S; Nakamura T; Watanabe H
Nihon Hinyokika Gakkai Zasshi; 1998 Nov; 89(11):894-8. PubMed ID: 9866379
[TBL] [Abstract][Full Text] [Related]
4. Newborn mass screening and selective screening using electrospray tandem mass spectrometry in Japan.
Shigematsu Y; Hirano S; Hata I; Tanaka Y; Sudo M; Sakura N; Tajima T; Yamaguchi S
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Aug; 776(1):39-48. PubMed ID: 12127323
[TBL] [Abstract][Full Text] [Related]
5. Mass screening for breast cancer: comparison of the clinical stages and prognosis of breast cancer detected by mass screening and in out-patient clinics.
Ota J; Horino T; Taguchi T; Ishida T; Izuo M; Ogita M; Abe R; Watanabe H; Morimoto T; Itoh S
Jpn J Cancer Res; 1989 Nov; 80(11):1028-34. PubMed ID: 2514163
[TBL] [Abstract][Full Text] [Related]
6. [Mass screening program for cancer].
Fujimoto I
Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):727-32. PubMed ID: 6712270
[TBL] [Abstract][Full Text] [Related]
7. The characteristics of interval breast cancer in mass screening.
Morimoto T; Komaki K; Oshimo K; Miki H; Sasa M; Mori T; Tsuzuki H; Kamamura Y; Monden Y
Tokushima J Exp Med; 1992 Dec; 39(3-4):109-16. PubMed ID: 1295127
[TBL] [Abstract][Full Text] [Related]
8. Mass screening for neuroblastoma and estimation of costs.
Nishi M; Miyake H; Takeda T; Takasugi N; Hanai J; Kawai T
Acta Paediatr Scand; 1991; 80(8-9):812-7. PubMed ID: 1957600
[TBL] [Abstract][Full Text] [Related]
9. Appropriate frequency of mass-screening for uterine cervical cancer.
Iwanari O
Nihon Sanka Fujinka Gakkai Zasshi; 1987 Oct; 39(10):1799-805. PubMed ID: 3429977
[TBL] [Abstract][Full Text] [Related]
10. A clinician's view of the mass screening of the newborn for inherited diseases: current practice and future considerations.
Sardharwalla IB; Wraith JE
J Inherit Metab Dis; 1989; 12 Suppl 1():55-63. PubMed ID: 2509812
[TBL] [Abstract][Full Text] [Related]
11. [Mass screening for breast cancer in Japan].
Ota J
Gan To Kagaku Ryoho; 1991 Oct; 18(13):2210-6. PubMed ID: 1929440
[TBL] [Abstract][Full Text] [Related]
12. [Mass screening prostate cancer and clinical comparison].
Zhao R; Kong XB; Zhang MC
Zhonghua Wai Ke Za Zhi; 2009 May; 47(10):734-6. PubMed ID: 19615204
[TBL] [Abstract][Full Text] [Related]
13. The impact of decreasing abdominal aortic aneurysm prevalence on a local aneurysm screening programme.
Darwood RJ; Brooks MJ
Eur J Vasc Endovasc Surg; 2012 Jul; 44(1):45-50. PubMed ID: 22578564
[TBL] [Abstract][Full Text] [Related]
14. Guidelines for Mass Screening of Congenital Hypothyroidism (2014 revision).
; ; ; Nagasaki K; Minamitani K; Anzo M; Adachi M; Ishii T; Onigata K; Kusuda S; Harada S; Horikawa R; Minagawa M; Mizuno H; Yamakami Y; Fukushi M; Tajima T
Clin Pediatr Endocrinol; 2015 Jul; 24(3):107-33. PubMed ID: 26594093
[TBL] [Abstract][Full Text] [Related]
15. Detection of early gastric cancer: misunderstanding the role of mass screening.
Suzuki H; Gotoda T; Sasako M; Saito D
Gastric Cancer; 2006; 9(4):315-9. PubMed ID: 17235635
[TBL] [Abstract][Full Text] [Related]
16. [Establishment of screening and confirmation method for the analysis of pesticide residues in tea by ultra-performance liquid chromatography-quadrupole-time-of-flight mass spectrometry].
Qiao Y; Wang J; Qiu Y; Qian Z; Hu H; Chen W; Wang P
Se Pu; 2020 Dec; 38(12):1402-1412. PubMed ID: 34213255
[TBL] [Abstract][Full Text] [Related]
17. [A comparative study of breast cancer mass screening and opportunistic screening in Chinese women].
Shen SJ; Xu YL; Zhou YD; Ren GS; Jiang J; Jiang HC; Zhang J; Li B; Jin F; Li YP; Xie FM; Shi Y; Wang ZD; Sun M; Yuan SH; Yu JJ; Chen Y; Sun Q
Zhonghua Wai Ke Za Zhi; 2021 Feb; 59(2):109-115. PubMed ID: 33378802
[No Abstract] [Full Text] [Related]
18. Impact of Mass Screening on the Number of Confirmed Cases, Recovered Cases, and Deaths Due to COVID-19 in Iran: An Interrupted Time Series Analysis.
Taheri Soodejani M; Tabatabaei SM; Dehghani A; McFarland W; Sharifi H
Arch Iran Med; 2020 Nov; 23(11):776-781. PubMed ID: 33220696
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a data-processing method for target and non-target screening using comprehensive two-dimensional gas chromatography coupled with high-resolution time-of-flight mass spectrometry for environmental samples.
Ieda T; Hashimoto S; Isobe T; Kunisue T; Tanabe S
Talanta; 2019 Mar; 194():461-468. PubMed ID: 30609559
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of an open screening method for doping substances in urine by gas chromatography quadrupole time-of-flight mass spectrometry.
Polet M; Van Gansbeke W; Van Eenoo P
Anal Chim Acta; 2018 Dec; 1042():52-59. PubMed ID: 30428988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
